NEW YORK (GenomeWeb) –Vela Diagnostics announced today it has licensed two methods from the University of California, San Francisco for enriching rare sequences, and plans to use the technologies to develop oncology and infectious disease tests, including for cell-free DNA and RNA testing and microbiology tests.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.